In This Article:
Needham analyst Ryan MacDonald raised the price forecast on Duolingo (NASDAQ:DUOL) from $385 to $400 while maintaining a Buy rating.
The company reported mixed fourth-quarter results on Thursday. Revenue of $209.6 million beat the consensus of $205.4 million, and EPS of $0.28 missed the consensus estimate of $0.50.
Duolingo sees revenues of $220.5 million – $223.5 million for the first quarter (vs. consensus of $221.069 million) and $962.5 million – $978.5 million for FY25 (vs. estimate of $965.882 million).
The analyst’s bullish stance reflects strong fourth-quarter results, with both revenue and earnings surpassing expectations.
Highlights include another quarter of 50%+ DAU growth and a surge in subscription bookings to 50%, fueled by early adoption of the premium Duolingo Max tier and an improved Family Plan mix, adds the analyst.
The analyst says that although shares are down due to a weaker-than-expected FY25 adjusted EBITDA guidance, he notes DUOL’s increased investments in enhancing its GenAI-powered Video Call feature positions it for long-term growth.
MacDonald writes that he is prepared to endure short-term challenges for long-term gains and sees the initial revenue guidance as conservative, which provides room for the company to maintain its beat-and-raise momentum in FY25.
Price Action: DUOL shares are down 14.11% at $322.74 at the last check Friday.
Read Next:
Photo via Shutterstock.
Latest Ratings for DUOL
| Mar 2022 | Evercore ISI Group | Maintains | Outperform | |
| Mar 2022 | Piper Sandler | Maintains | Overweight | |
| Jan 2022 | Piper Sandler | Maintains | Overweight |
View More Analyst Ratings for DUOL
View the Latest Analyst Ratings
UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets.
Get the latest stock analysis from Benzinga?
This article Duolingo's AI Investments Set The Stage For Long-Term Growth—Analyst Sees Stock Hitting $400 originally appeared on Benzinga.com
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.